Possibilities of pharmacological correction of the artifical bladder contractile activity in experimental conditions in vivo.

The aim of this work was to study the possibility of pharmacological correction of the neobladder contractile activity of mini-pigs under the influence of new chemical compounds, m-anticholinergic (solifenacin), selective beta-2 sympathomimetic (ginipral (hexoprenaline)) in vivo. Neobladder, formed...

Full description

Saved in:
Bibliographic Details
Main Authors: R. V. Savchuk, F. I. Kostyev, N. V. Shmatkova
Format: Article
Language:English
Published: Dnipro State Medical University 2020-10-01
Series:Medičnì Perspektivi
Subjects:
Online Access:https://journals.uran.ua/index.php/2307-0404/article/view/189183
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839649244477128704
author R. V. Savchuk
F. I. Kostyev
N. V. Shmatkova
author_facet R. V. Savchuk
F. I. Kostyev
N. V. Shmatkova
author_sort R. V. Savchuk
collection DOAJ
description The aim of this work was to study the possibility of pharmacological correction of the neobladder contractile activity of mini-pigs under the influence of new chemical compounds, m-anticholinergic (solifenacin), selective beta-2 sympathomimetic (ginipral (hexoprenaline)) in vivo. Neobladder, formed from the distal section of ileum, pre-denervated along the anti-mesenteric margin, retains peristalsis, and  given the sharp thickening of the muscle layer, capable to contractile reactions and tone support. New chemical compounds pyrrole-2-carbaldehyde 2- hydroxybenzoylhydrazone (PChBh) and isatin benzoylhydrazone (IBh) demonstrated spasmodic properties directed at smooth muscle in vivo. Compound PChBh (I) showed more pronounced relaxing properties compared to compound IBh (II), reducing basal pressure against KCl by 40.91%, contraction amplitude by 30.63%, contraction rate by 25.49%. Solifenacin, being an m-anticholinergic antagonist, most clearly demonstrated antispasmodic properties in vivo, reducing hypertonicity by 55.23%, amplitude – by 49.31%, frequency of contractions in 10 minutes – by 57.40%, duration of contractions – by 18.18%. Selective beta-2-sympathomimetic hexoprenaline, previously used to relieve hypertonicity of a pregnant uterus actively affects intestinal motility. Hexoprenaline inhibited bladder overactivity with KCl, decreasing basal pressure by 58.75%, the amplitude of the contractions – by 39.62%, frequency rate – by 57.49%, reductions in the duration – by 54.55%. Preparations from the group of m-anticholinergics and selective beta-2-sympathomimetics showed a pronounced antispasmodic effect in experiment in vivo and can be used to correct incontinence in patients after orthotopic bladder repair. The new chemical compounds pyrrole-2-carbaldehyde 2-hydroxybenzoylhydrazone (PChBh) and isatin benzoylhydrazone (IBh) demonstrated antispasmodic properties in the experiment in vitro, and confirmed an antispasmodic effect in the experiment in vivo, promising further research, determining safety and efficacy.
format Article
id doaj-art-4cc0429e5fb8450cb44e00a43a1b1c1b
institution Matheson Library
issn 2307-0404
2786-4804
language English
publishDate 2020-10-01
publisher Dnipro State Medical University
record_format Article
series Medičnì Perspektivi
spelling doaj-art-4cc0429e5fb8450cb44e00a43a1b1c1b2025-06-27T10:23:39ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042786-48042020-10-0124410.26641/2307-0404.2019.4.189183Possibilities of pharmacological correction of the artifical bladder contractile activity in experimental conditions in vivo.R. V. SavchukF. I. KostyevN. V. ShmatkovaThe aim of this work was to study the possibility of pharmacological correction of the neobladder contractile activity of mini-pigs under the influence of new chemical compounds, m-anticholinergic (solifenacin), selective beta-2 sympathomimetic (ginipral (hexoprenaline)) in vivo. Neobladder, formed from the distal section of ileum, pre-denervated along the anti-mesenteric margin, retains peristalsis, and  given the sharp thickening of the muscle layer, capable to contractile reactions and tone support. New chemical compounds pyrrole-2-carbaldehyde 2- hydroxybenzoylhydrazone (PChBh) and isatin benzoylhydrazone (IBh) demonstrated spasmodic properties directed at smooth muscle in vivo. Compound PChBh (I) showed more pronounced relaxing properties compared to compound IBh (II), reducing basal pressure against KCl by 40.91%, contraction amplitude by 30.63%, contraction rate by 25.49%. Solifenacin, being an m-anticholinergic antagonist, most clearly demonstrated antispasmodic properties in vivo, reducing hypertonicity by 55.23%, amplitude – by 49.31%, frequency of contractions in 10 minutes – by 57.40%, duration of contractions – by 18.18%. Selective beta-2-sympathomimetic hexoprenaline, previously used to relieve hypertonicity of a pregnant uterus actively affects intestinal motility. Hexoprenaline inhibited bladder overactivity with KCl, decreasing basal pressure by 58.75%, the amplitude of the contractions – by 39.62%, frequency rate – by 57.49%, reductions in the duration – by 54.55%. Preparations from the group of m-anticholinergics and selective beta-2-sympathomimetics showed a pronounced antispasmodic effect in experiment in vivo and can be used to correct incontinence in patients after orthotopic bladder repair. The new chemical compounds pyrrole-2-carbaldehyde 2-hydroxybenzoylhydrazone (PChBh) and isatin benzoylhydrazone (IBh) demonstrated antispasmodic properties in the experiment in vitro, and confirmed an antispasmodic effect in the experiment in vivo, promising further research, determining safety and efficacy. https://journals.uran.ua/index.php/2307-0404/article/view/189183neobladderpharmacological correctionexperimental in vivonew chemical compounds
spellingShingle R. V. Savchuk
F. I. Kostyev
N. V. Shmatkova
Possibilities of pharmacological correction of the artifical bladder contractile activity in experimental conditions in vivo.
Medičnì Perspektivi
neobladder
pharmacological correction
experimental in vivo
new chemical compounds
title Possibilities of pharmacological correction of the artifical bladder contractile activity in experimental conditions in vivo.
title_full Possibilities of pharmacological correction of the artifical bladder contractile activity in experimental conditions in vivo.
title_fullStr Possibilities of pharmacological correction of the artifical bladder contractile activity in experimental conditions in vivo.
title_full_unstemmed Possibilities of pharmacological correction of the artifical bladder contractile activity in experimental conditions in vivo.
title_short Possibilities of pharmacological correction of the artifical bladder contractile activity in experimental conditions in vivo.
title_sort possibilities of pharmacological correction of the artifical bladder contractile activity in experimental conditions in vivo
topic neobladder
pharmacological correction
experimental in vivo
new chemical compounds
url https://journals.uran.ua/index.php/2307-0404/article/view/189183
work_keys_str_mv AT rvsavchuk possibilitiesofpharmacologicalcorrectionoftheartificalbladdercontractileactivityinexperimentalconditionsinvivo
AT fikostyev possibilitiesofpharmacologicalcorrectionoftheartificalbladdercontractileactivityinexperimentalconditionsinvivo
AT nvshmatkova possibilitiesofpharmacologicalcorrectionoftheartificalbladdercontractileactivityinexperimentalconditionsinvivo